Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
OOEP pseudogene 1 (OOEPP1) is classified as a pseudogene corresponding to the oocyte expressed protein (OOEP) gene. Pseudogenes are genomic DNA sequences similar to normal genes but are non-functional due to mutations or lack of regulatory elements. Most pseudogenes, including OOEPP1, do not code for functional proteins, although some can be transcribed into RNA with potential regulatory effects such as modulation of microRNA activity or expression of neighboring genes. OOEPP1 is not considered a direct therapeutic target, receptor, enzyme, or transcription factor, but pseudogenes in general may influence disease states through indirect gene regulatory mechanisms[2][5][3]. No known drug interactions, disease biomarker uses, or safety issues are reported for OOEPP1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on OOEP pseudogene 1 (OOEPP1).